𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B

✍ Scribed by Matti Sällberg; Helene Norder; Lars O. Magnius


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
589 KB
Volume
30
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The IgG subclasses IgM and IgA1 of antibodies to hepatitis B core antigen (anti‐HBc) and hepatitis B e antigen (anti‐HBe) were assayed in sera from 82 patients with chronic hepatitis B utilising class/subclass‐specific enzyme immunoassays (EIA). The solid‐phase was either recombinant hepatitis B core antigen (rHBcAg) or rHBcAg converted to HBeAg by addition of 0.1% SDS with remaining HBcAg antigenicity blocked with monoclonal anti‐HBc. Anti‐HBc IgG1 was detected in 81 sera at a geometrical mean titre (GMT) of 296, 110 2.9. Anti‐HBc IgG2 was not detected in any of the sera, and anti‐HBc IgG3 and IgG4 were detected in 50 and 37 sera, respectively. Anti‐HBc IgM and IgA1 were both significantly correlated to the presence of HBV DNA. The predominant antibody to HBeAg was found to be IgG1, being detected in 45 sera with a GMT of 1,035 3.3. Anti‐HBe IgG2 was not detected in any serum, while anti‐HBe IgG3 and IgG4 were found in 8 and 23 sera, respectively. Anti‐HBe IgG1, IgG3, and IgG4 were mainly detected in sera positive for anti‐HBe in RIA (Abbott). No patient was found positive for anti‐HBe IgA1 or IgM. Thus, in contrast to HBcAg, HBeAg does not trigger a persistent IgM and IgA1 response in chronic hepatitis B. The levels of anti‐HBe IgG1 and IgG3 were much lower than the levels of anti‐HBc IgG1 and IgG3. The presence of anti‐HBe IgG4 was significantly correlated to that of anti‐HBc IgG4. The relative levels of anti‐HBc IgG subclasses were found to be IgG1 > IgG3 > IgG4, whereas the relative levels of anti‐HBe subclasses were IgG1 ≥ IgG4 ≥ IgG3. The anti‐HBe IgG1:IgG4 ratio was much lower than that of anti‐HBc, 2.7:1 versus 890:1. Our findings support the suggestion of differences at the B‐cell level in the regulation of the immunoresponse to HBeAg and HBcAg, though both antigenic epitopes reside on the same polypeptide.


📜 SIMILAR VOLUMES


The significance of IgM antibodies to he
✍ S. Victor Feinman; Lacy R. Overby; Barnet Berris; Kurt Chau; Charles A. Schable; 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

IgM antibody to hepatitis B core antigen (IgM anti-HBc) was determined in 60 patients whose serum was positive for hepatitis B surface antigen (HBsAg) and 18 patients whose serum was negative for HBsAg, but positive for antibody to hepatitis B core antigen (anti-HBc). Two radioimmunoassap were done

Dane Particle-Associated Hepatitis B e A
✍ Giovanni Raimondo; Serafino Recchia; Carla Lavarini; Osvaldo Crivelli; Mario Riz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

A commercial radioimmunoassay was adapted to detect serum Dane particle-associated HBeAg in patients whose sera contained the homologous antibody. HBeAg was released from Dane particles with guanidine HC1. Dane particles were separated from anti-HBe by gel-filtration (Sepharose 4B) and ultracentrif

Natural course and response to interfero
✍ Maurizia Rossana Brunetto; Filippo Oliveri; Giuseppe Rocca; Domenico Criscuolo; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

The course of chronic hepatitis B was studied in 30 patients who had antibody to hepatitis e antigen and hepatitis B virus DNA in the serum and hepatitis B core antigen in the liver. Over a 2-year period, no patient experienced a sustained spontaneous remission of disease, and follow-up liver histol

Association of concurrent hepatitis B su
✍ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t